TickerFacts.

AbCellera Biologics Inc. (ABCL): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$212.81M
Year ended 2023-12-31
$244.35M2019-12-31: -$2.51M2020-12-31: $160.87M2021-12-31: $218.86M2022-12-31: $244.35M2023-12-31: -$212.81M-$212.81M
2019-12-31 EBITDA (USD) 2023-12-31
Period endedEBITDAChange YoYSource filing
2023-12-31-$212.81Mn/m2026-02-24, From 2023-01-01
2022-12-31$244.35M+11.6%2025-02-27, From 2022-01-01
2021-12-31$218.86M+36.1%2024-02-20, From 2021-01-01
2020-12-31$160.87Mn/m2023-02-21, From 2020-01-01
2019-12-31-$2.51Mn/a2022-02-25, From 2019-01-01